References
- Steinhubl SR, Berger PB, Mann JT, 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. CREDO Investigators. Early and sustained dual antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. J Am Med Assoc 2002; 188: 2411–2420
- Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany VL. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: The Plavix Reduction Of New Thrombus Occurance (PRONTO) trial. Am Heart J 2003; 145: 239–247
- Gawaz M, Neumann FJ, Ott I, May A, Rüdiger S, Schömig A. Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. Heart 1996; 76: 166–172
- Gutensohn K, Beythien C, Bau J, Meinertz T, Kuehnl P. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model. Thromb Res 1997; 86: 49–56
- Gawaz M, Neumann FJ, Ott I, May A, Schömig A. Platelet activation and coronary stent implantation. Effect of antiplatelet therapy. Circulation 1996; 94: 279–285